Abstract
We present a case of delta-aminolevulinic acid dehydratase-porphyria (ADP) who was successfully treated by suppressing bone-marrow production of toxic heme precursors. Together with supporting evidence from earlier cases, it is likely ADP has both hepatic and erythroid origins. This article is protected by copyright. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 434-436 |
| Number of pages | 3 |
| Journal | Hepatology (Baltimore, Md.) |
| Volume | 70 |
| Issue number | 1 |
| Early online date | 6 Feb 2019 |
| DOIs | |
| Publication status | Published - Jul 2019 |
Fingerprint
Dive into the research topics of 'Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency through Suppression of Erythroid Heme Synthesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver